Clinical Trial Update: The SURGICEL® Powder Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding (China Study) [NA]

View source ↗

Summary

A completed clinical trial update on SURGICEL Powder for intraoperative bleeding in China; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage

Drugs mentioned

• SURGICEL Powder (oxidized regenerated cellulose)

Snippet

Sponsor: Ethicon, LLC | Conditions: Hemorrhage | NA | Status: COMPLETED | Results posted: 2020-12-22